Mangalam Drugs & Organics (NSE:MANGALAM) Inventory Turnover: 0.46 (As of Mar. 2026)

What is Mangalam Drugs & Organics Inventory Turnover?

Mangalam Drugs & Organics NSE:MANGALAM +1.80% 43 Inventory Turnover is 0.46 as of Mar. 2026. GuruFocus rates NSE:MANGALAM with a GF Score™ of 43/100 and a GF Value™ of ₹62.92 (Possible Value Trap). The stock has 4 warning signs investors should review.

Inventory Turnover measures how fast the company turns over its inventory within a year. It is calculated as Cost of Goods Sold divided by Total Inventories. Mangalam Drugs & Organics's Cost of Goods Sold for the three months ended in Mar. 2026 was ₹472 Mil. Mangalam Drugs & Organics's Average Total Inventories for the quarter that ended in Mar. 2026 was ₹1,028 Mil. Mangalam Drugs & Organics's Inventory Turnover for the quarter that ended in Mar. 2026 was 0.46.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Mangalam Drugs & Organics's Days Inventory for the three months ended in Mar. 2026 was 198.85.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Mangalam Drugs & Organics's Inventory-to-Revenue for the quarter that ended in Mar. 2026 was 1.53.

Mangalam Drugs & Organics (NSE:MANGALAM) Inventory Turnover Explanation

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher Inventory Turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Mangalam Drugs & Organics's Days Inventory for the three months ended in Mar. 2026 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Mar. 2026 )	/	Cost of Goods Sold (Q: Mar. 2026 )	*	Days in Period
	=	1027.736	/	471.625	*	365 / 4
	=	198.85

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Mangalam Drugs & Organics's Inventory to Revenue for the quarter that ended in Mar. 2026 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Mar. 2026 )	/	Revenue (Q: Mar. 2026 )
	=	1027.736	/	672.871
	=	1.53

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate Inventory Turnover. An average inventory is a better indication.

Mangalam Drugs & Organics Inventory Turnover Related Terms

Mangalam Drugs & Organics Inventory Turnover Historical Data

* Premium members only.

The historical data trend for Mangalam Drugs & Organics's Inventory Turnover can be seen below:

Mangalam Drugs & Organics Inventory Turnover Chart

Mangalam Drugs & Organics Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Mar26

Inventory Turnover

Get a 7-Day Free Trial

3.67

2.10

2.02

1.28

1.30

Mangalam Drugs & Organics Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Inventory Turnover	Get a 7-Day Free Trial															0.25	0.30	0.28	0.32	0.46

43GF Score

Mangalam Drugs & Organics Ltd NSE:MANGALAM

Inventory Turnover is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Mangalam Drugs & Organics Inventory Turnover Calculation

Mangalam Drugs & Organics's Inventory Turnover for the fiscal year that ended in Mar. 2026 is calculated as

	Inventory Turnover (A: Mar. 2026 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (A: Mar. 2026 )	/ (	(Total Inventories (A: Mar. 2025 )	+	Total Inventories (A: Mar. 2026 ))	/	count )
=	1568.757	/ (	(1388.018	+	1027.736)	/	2 )
=	1568.757	/	1207.877
=	1.30

Mangalam Drugs & Organics's Inventory Turnover for the quarter that ended in Mar. 2026 is calculated as

	Inventory Turnover (Q: Mar. 2026 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (Q: Mar. 2026 )	/ (	(Total Inventories (Q: Dec. 2025 )	+	Total Inventories (Q: Mar. 2026 ))	/	count )
=	471.625	/ (	(0	+	1027.736)	/	1 )
=	471.625	/	1027.736
=	0.46

Frequently Asked Questions Learn more about Inventory Turnover →

What does a Inventory Turnover of 0.46 mean?

Mangalam Drugs & Organics (NSE:MANGALAM) has a Inventory Turnover of 0.46 as of Mar. 2026. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on Mangalam Drugs & Organics and its competitors.

Is Mangalam Drugs & Organics' Inventory Turnover too high?

Mangalam Drugs & Organics' current Inventory Turnover is 0.46. Overall, Mangalam Drugs & Organics has a GF Score™ of 43/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.

How does Mangalam Drugs & Organics' Inventory Turnover compare to ZTS and UTHR?

Mangalam Drugs & Organics' Inventory Turnover of 0.46 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Inventory Turnover for a Drug Manufacturers company?

A good Inventory Turnover depends on the Drug Manufacturers industry context. However, Inventory Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Inventory Turnover mean?

A high Inventory Turnover can signal that a stock is expensive relative to its fundamentals. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on Mangalam Drugs & Organics and its competitors. Mangalam Drugs & Organics's current Inventory Turnover is 0.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Mangalam Drugs & Organics stock overvalued right now?

Based on GuruFocus' analysis, Mangalam Drugs & Organics (NSE:MANGALAM) is currently considered Possible Value Trap. The stock's GF Value™ is ₹62.92, compared to a current price of ₹27.75 — trading 55.9% below its estimated fair value. The current Inventory Turnover is 0.46. Mangalam Drugs & Organics' overall GF Score™ is 43/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Inventory Turnover calculated?

Inventory Turnover is calculated from a company's financial statements. For Mangalam Drugs & Organics (NSE:MANGALAM), the current Inventory Turnover is 0.46 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Mangalam Drugs & Organics (NSE:MANGALAM) Overvalued in 2026?

Based on GuruFocus' analysis, Mangalam Drugs & Organics stock appears to be undervalued. The current stock price of ₹27.75 is trading 55.9% below its estimated GF Value™ of ₹62.92. GuruFocus considers Mangalam Drugs & Organics to be Possible Value Trap.

Key valuation signals for NSE:MANGALAM:

Inventory Turnover: 0.46
GF Value™: ₹62.92 vs. price of ₹27.75 (55.9% below fair value)
GF Score™: 43/100 with 4 warning signs

No single metric tells the full story. See the NSE:MANGALAM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Mangalam Drugs & Organics Business Description

Industry Healthcare Drug Manufacturers

Comparable Companies BOM:524711 BOM:532660 BOM:543963 BOM:524703 BOM:540702 BOM:540694 BOM:524516 BOM:524322 BOM:542248 BOM:524396 XTER:MRK XSWX:GALD TSE:4502 SHSE:600276 NSE:SUNPHARMA LSE:HLN XTAE:TEVA XSWX:SDZ ZTS UTHR

Other Exchanges 532637:India

Address P. D'Mello Road, Rupam Building, 3rd Floor, No. 239, Near General Post Office, Mumbai, MH, IND, 400001

Website https://www.mangalamdrugs.com

Mangalam Drugs & Organics Ltd commenced its manufacturing of Active Pharmaceutical Ingredients (APIs) and intermediates. The company is engaged in the manufacture and sale of APIs for various therapeutic segments, including anti-malaria, anti-retroviral, and anti-hypertensive. It is approved by the Bill Clinton Foundation. The company is actively producing Pyronaridine Tetraphosphate, a new API used in antimalarial treatments. The company has received prequalification from the World Health Organization (WHO) for both micronized and non-micronized forms of Pyronaridine Phosphate.

43GF Score

Get the complete analysis for NSE:MANGALAM

Inventory Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹27.75

Price

₹62.92

GF Value

View NSE:MANGALAM Analysis

See Inventory Turnover data for all stocks →